Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) was down 12.2% on Monday. The stock traded as low as C$3.90 and last traded at C$3.95. 4,697 shares were traded during mid-day trading, an increase of 39% from the average daily volume of 3,375 shares. The stock had previously closed at C$4.50.
Genscript Biotech Price Performance
The firm has a fifty day simple moving average of C$4.68 and a two-hundred day simple moving average of C$2.58.
Genscript Biotech Company Profile
GenScript Biotech is a biotechnology company founded in 2002 and based in Nanjing, China. It provides research tools and services to pharmaceutical and biotechnology companies, academic institutions, and other organizations worldwide. Its life-science services include gene and peptide synthesis, oligonucleotides, proteins, antibodies, and related research and development support. The company also offers biologics development and manufacturing services through its ProBio business, serving customers developing therapeutic products.
See Also
- Five stocks we like better than Genscript Biotech
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
